Prediction of vasopressor requirement among hypotensive patients with suspected infection: usefulness of diastolic shock index and lactate

Objective We evaluated the performance of diastolic shock index (DSI) and lactate in predicting vasopressor requirement among hypotensive patients with suspected infection in an emergency department.Methods This was a single-center, retrospective observational study for adult patients with sus-pected infection and hypotension in the emergency department from 2018 to 2019. The study population was split into derivation and validation cohorts (70/30). We derived a simple risk score to predict vasopressor requirement using DSI and lactate cutoff values determined by Youden index. We tested the score by the area under the receiver operating characteristic curve (AUC). We performed a multivariable regression analysis to evaluate the association between the timing of vasopressor treatment and 28-day mortality.Results A total of 1,917 patients were included. We developed a score, assigning 1 point each for the high DSI (>= 2.0) and high lactate (>= 2.5 mmol/L) criteria. The AUCs of the score were 0.741 (95% confidence interval [CI], 0.715-0.768) at hypotension and 0.736 (95% CI, 0.708- 0.763) after initial fluid challenge in the derivation cohort and 0.676 (95% CI, 0.631-0.719) at hypotension and 0.688 (95% CI, 0.642-0.733) after initial fluid challenge in the validation co-hort, respectively. In patients with scores of 2 points, early vasopressor therapy initiation was significantly associated with decreased 28-day mortality (adjusted odds ratio, 0.37; 95% CI, 0.14- 0.94).Conclusion A prediction model with DSI and lactate levels might be useful to identify patients who are more likely to need vasopressor administration among hypotensive patients with sus-pected infection.

Automated summary

This study found that a prediction model using diastolic shock index and lactate levels could help identify patients who are more likely to need vasopressor administration among hypotensive patients with suspected infection. Early initiation of vasopressor therapy was significantly associated with decreased 28-day mortality in patients with a score of 2 points.